Is Aurobindo FDA approved?
Is Aurobindo FDA approved?
Aurobindo Pharma gets USFDA approval for drug used to sedate patients. Drug major Aurobindo Pharma On Wednesday said it has received final approval from the US health regulator for generic of Precedex injection, used for sedation of patients.
Are Aurobindo drugs safe?
India’s Aurobindo Pharma has been one of the culprits found manufacturing the high blood pressure medicine valsartan with high levels of impurities that carry a risk of cancer. Now the FDA has savaged it in a warning letter for missteps that paved the pathway to the mess.
Can the FDA send warning letters?
The FDA defines an FDA warning letter as: Warning Letters should only be issued for violations of regulatory significance, i.e., those that may actually lead to an enforcement action if the documented violations are not promptly and adequately corrected.
Is Aurobindo Pharma partner of Pfizer?
Its marketing partners include AstraZeneca and Pfizer….Aurobindo Pharma.
| Type | Public |
|---|---|
| Revenue | ₹23,290 crore (US$3.3 billion) (2020) |
| Operating income | ₹4,063 crore (US$570 million) (2020) |
| Net income | ₹2,844 crore (US$400 million) (2020) |
| Total assets | ₹28,926 crore (US$4.1 billion) (2020) |
Who is the owner of Aurobindo Pharma?
Aurobindo Pharma was founded in 1986 by Mr. P. V. Ramaprasad Reddy and Mr.
Where is drug manufacturer Aurobindo located?
Srikakulam District
The U.S. Food and Drug Administration (FDA) inspected your drug manufacturing facility, Aurobindo Pharma Limited (APL), Unit XI at Sy. No. 61-66, IDA, Pydibhimavaram, Ranasthalam (Mandal), Srikakulam District, AP, from February 4 to 9, 2019.
Is Aurobindo a good drug company?
Aurobindo’s inability to resolve the problems before they led to an OAI continues the company’s bad run with the US FDA. Last year, the US FDA classified three Aurobindo facilities as OAI. No other company received more than two OAI classifications related to drug quality assurance last year.
What are the side effects of Aurobindo?
Nausea, vomiting, headache, bloating, breast tenderness, swelling of the ankles/feet (fluid retention), or weight change may occur. Vaginal bleeding between periods (spotting) or missed/irregular periods may occur, especially during the first few months of use.
How serious is an FDA warning letter?
A warning letter indicates that higher FDA officials have reviewed the observations and that a serious violation may exist. This formal notification allows for voluntary and prompt correction action. Sites are required to respond to warning letters in writing, typically within 15 days.
Are FDA inspection reports public?
Disclosure of a firm’s inspection information encourages firm compliance and provides the public with an understanding of the Agency’s enforcement actions and an ability to make more informed marketplace choices. Some inspection data may be not be posted until a final enforcement action is taken.
Is Aurobindo Pharma a good buy?
Traders are bullish on the stock for the short term with an expected price appreciation of around 7-10% from the current levels of Rs 308 in the next 3-4 weeks. Aurobindo Pharma is a classic strong balance sheet company where investors can buy the stock for smart gains.
Which is the largest pharmaceutical company in the world?
1. roche $49.5. Roche maintains its position as the largest company by pharmaceutical sales in 2021. With a workforce of over 90,000 and headquarters based in Basel Switzerland, Roche is at the forefront of oncology, immunology, infectious diseases, ophthalmology and neuroscience.
Where is Aurobindo Pharma located in Srikakulam district?
The U.S. Food and Drug Administration (FDA) inspected your drug manufacturing facility, Aurobindo Pharma Limited (APL), Unit XI at Sy. No. 61-66, IDA, Pydibhimavaram, Ranasthalam (Mandal), Srikakulam District, AP, from February 4 to 9, 2019.
How to contact Nabeel Babaa for Aurobindo unit XI?
Contact Nabeel Babaa, by e-mail at [email protected], within five business days of receipt of this letter to schedule a regulatory meeting to discuss CGMP compliance at Aurobindo Unit XI (FEI: 3004611182), Aurobindo Unit I (FEI: 3004021253), and Aurobindo Unit IX (FEI: 3006370489).
Is there a warning letter for active pharmaceutical ingredients?
This warning letter summarizes significant deviations from current good manufacturing practice (CGMP) for active pharmaceutical ingredients (API).
Where do I Send my FOI request to the FDA?
To obtain additional available information, contact FDA. Requests to FDA for agency records should be sent to: Food and Drug Administration Division of Freedom of Information (HFI-35), 5630 Fishers Lane, Rockville, MD 20857. Instructions for how to submit an FOI request can be found at How to Make a FOIA Request.